Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering MolPort-002-051-769

Client Email

Product

MolPort-002-051-769
US Patents

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

MolPort-002-051-769

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 12 USDMF, 6 CEP/COS, 2 JDMF, 6 EU WC, 14 NDC API, 16 Listed Suppliers, $ API Reference Price

24 API Suppliers
12 USDMF
6 CEP/COS
2 JDMF
6 EU WC
14 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

257 FDF Dossiers, 112 FDA Orange Book, 81 Europe, 26 Canada, 8 South Africa, 30 Listed Dossiers

257 FDF Dossiers
112 FDA Orange Book
81 Europe
26 Canada
8 South Africa
30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, INJECTABLE;INJECTION - 2MG/ML, INJECTABLE;INJECTION - 4MG/ML

TABLET;ORAL - 0.5MG
TABLET;ORAL - 1MG
TABLET;ORAL - 2MG
INJECTABLE;INJECTION - 2MG/ML
INJECTABLE;INJECTION - 4MG/ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 Seqens, 1 Jai Radhe Sales, 1 Chynops Pharma, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 3 Finar, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 31 Direct Compression, 25 Disintegrants & Superdisintegrants, 24 Controlled & Modified Release, 20 Thickeners and Stabilizers, 17 Lubricants & Glidants, 17 Granulation, 15 Co-Processed Excipients, 13 Topical, 10 Taste Masking, 9 Film Formers & Plasticizers, 9 Solubilizers, 8 Chewable & Orodispersible Aids, 6 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Rheology Modifiers, 3 API Stability Enhancers, 3 Emulsifying Agents, 2 Coloring Agents, 1 Surfactant & Foaming Agents

60 Fillers, Diluents & Binders
41 Coating Systems & Additives
31 Direct Compression
25 Disintegrants & Superdisintegrants
24 Controlled & Modified Release
20 Thickeners and Stabilizers
17 Lubricants & Glidants
17 Granulation
15 Co-Processed Excipients
13 Topical
10 Taste Masking
9 Film Formers & Plasticizers
9 Solubilizers
8 Chewable & Orodispersible Aids
6 Parenteral
5 Empty Capsules
4 Vegetarian Capsules
3 Rheology Modifiers
3 API Stability Enhancers
3 Emulsifying Agents
2 Coloring Agents
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 20 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 106 Finished Drug Prices, 5 Annual Reports

2 US Medicaid Prescriptions
106 Finished Drug Prices
5 Annual Reports

MARKET PLACE

9 APIs, 10 FDF Dossiers

9 APIs
10 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 18 Others

3 EDQM
4 USP
18 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 991 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4ALMATICA

filter Patent Number Reset all filters

4 All

01 48999393

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 42034-01-08

Product Main Page

01

ALMATICA

AAPS 2024

Not Confirmed

ALMATICA

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-08

US Patent Number : 8999393

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214826

Patent Use Code : U-3210

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ALMATICA

AAPS 2024

Not Confirmed

ALMATICA

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-08

US Patent Number : 8999393

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214826

Patent Use Code : U-3210

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ALMATICA

AAPS 2024

Not Confirmed

ALMATICA

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-08

US Patent Number : 8999393

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214826

Patent Use Code : U-3210

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ALMATICA

AAPS 2024

Not Confirmed

ALMATICA

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-08

US Patent Number : 8999393

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214826

Patent Use Code : U-3210

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?